Literature DB >> 16243583

Homing to suppress: address codes for Treg migration.

Jochen Huehn1, Alf Hamann.   

Abstract

Compelling evidence suggests that diverse types of immune reactions can be suppressed by CD25+ CD4+ regulatory T cells (Tregs). Although increasing knowledge has accumulated concerning the generation and functional properties of Tregs, relatively little attention has been paid to another key question: where does immune regulation by Tregs take place in vivo? Tregs can inhibit both the priming and the effector phase of an immune response, so suppression might occur both within lymphoid tissues and at peripheral sites during immune reactions. This leads to the hypothesis that appropriate localization is indispensable for in vivo Treg function and that the migratory behavior of Treg subsets influences their in vivo suppressive capacity. Current data suggest a division of labor between subpopulations of Tregs, which is mainly based on specialized homing patterns.

Entities:  

Mesh:

Year:  2005        PMID: 16243583     DOI: 10.1016/j.it.2005.10.001

Source DB:  PubMed          Journal:  Trends Immunol        ISSN: 1471-4906            Impact factor:   16.687


  59 in total

1.  Histamine H4 receptor optimizes T regulatory cell frequency and facilitates anti-inflammatory responses within the central nervous system.

Authors:  Roxana del Rio; Rajkumar Noubade; Naresha Saligrama; Emma H Wall; Dimitry N Krementsov; Matthew E Poynter; James F Zachary; Robin L Thurmond; Cory Teuscher
Journal:  J Immunol       Date:  2011-12-05       Impact factor: 5.422

Review 2.  Antigen-presenting cell function in the tolerogenic liver environment.

Authors:  Angus W Thomson; Percy A Knolle
Journal:  Nat Rev Immunol       Date:  2010-11       Impact factor: 53.106

Review 3.  Regulatory T cell migration during an immune response.

Authors:  Yaozhong Ding; Jiangnan Xu; Jonathan S Bromberg
Journal:  Trends Immunol       Date:  2012-02-02       Impact factor: 16.687

Review 4.  Tolerance regeneration by T regulatory cells in autologous haematopoietic stem cell transplantation for autoimmune diseases.

Authors:  Kevin Hendrawan; Malini Visweswaran; David D F Ma; John J Moore
Journal:  Bone Marrow Transplant       Date:  2019-10-16       Impact factor: 5.483

5.  Generation of regulatory dendritic cells and CD4+Foxp3+ T cells by probiotics administration suppresses immune disorders.

Authors:  Ho-Keun Kwon; Choong-Gu Lee; Jae-Seon So; Chang-Suk Chae; Ji-Sun Hwang; Anupama Sahoo; Jong Hee Nam; Joon Haeng Rhee; Ki-Chul Hwang; Sin-Hyeog Im
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-13       Impact factor: 11.205

Review 6.  The plasticity of human Treg and Th17 cells and its role in autoimmunity.

Authors:  Markus Kleinewietfeld; David A Hafler
Journal:  Semin Immunol       Date:  2013-11-05       Impact factor: 11.130

7.  Host immunity contributes to the anti-melanoma activity of BRAF inhibitors.

Authors:  Deborah A Knight; Shin Foong Ngiow; Ming Li; Tiffany Parmenter; Stephen Mok; Ashley Cass; Nicole M Haynes; Kathryn Kinross; Hideo Yagita; Richard C Koya; Thomas G Graeber; Antoni Ribas; Grant A McArthur; Mark J Smyth
Journal:  J Clin Invest       Date:  2013-02-01       Impact factor: 14.808

8.  Why functional pre-erythrocytic and bloodstage malaria vaccines fail: a meta-analysis of fully protective immunizations and novel immunological model.

Authors:  D Lys Guilbride; Pawel Gawlinski; Patrick D L Guilbride
Journal:  PLoS One       Date:  2010-05-19       Impact factor: 3.240

9.  FOXP3 expression is upregulated in CD4T cells in progressive HIV-1 infection and is a marker of disease severity.

Authors:  Melinda S Suchard; Elizabeth Mayne; Victoria A Green; Sharon Shalekoff; Samantha L Donninger; Wendy S Stevens; Clive M Gray; Caroline T Tiemessen
Journal:  PLoS One       Date:  2010-07-23       Impact factor: 3.240

10.  Tumor-associated macrophages recruit CCR6+ regulatory T cells and promote the development of colorectal cancer via enhancing CCL20 production in mice.

Authors:  Jinlin Liu; Ning Zhang; Qun Li; Weiwei Zhang; Fang Ke; Qibin Leng; Hong Wang; Jinfei Chen; Honglin Wang
Journal:  PLoS One       Date:  2011-04-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.